Under pressure to look good on Instagram, millennials inspired by Kim Kardashian’s curves helped drive a record number of Brazilian butt lifts and a booming plastic surgery market in the United States last year.
Drinking soda, sports drinks and other sugary beverages increases the risk of dying from heart disease and some types of cancers, according to new research.
“The thing that’s going to be really interesting is the longevity of a lot of these devices,” Viskontas said. “You know, whether the pain relief is going to last or if it is just going to be taken over by the next thing, when the person realizes that their pain hasn’t gone away.” Jennifer Hah,
Investors and dieters, curiously, share a basic commonality: Each relies on numbers to measure performance. While the former long for an explosive surge upward and the latter a rapid decline, the numbers nevertheless gauge success.
Five years ago, Dr. Giovanni Traverso was perplexed when a patient began to have negative reactions to a common medication he prescribed.
What happened when Warren Buffett, Jamie Dimon and Jeff Bezos, technology’s biggest power player, got together to try to disrupt health care?
Aurora Cannabis Executive Chairman Michael Singer told CNBC that the company’s new partnership with activist investor Nelson Peltz is one of many strategic relationships it hopes to foster as it works to broaden its product portfolio.
UnitedHealth said Tuesday all of its new employer-sponsored plans in 2020 will pass discounts paid to so-called pharmacy benefits managers, or PBMs, to consumers at the pharmacy counter.
One in three people is at risk for diabetes. So 23andMe set out to develop the first direct-to-consumer genetic test to assess whether its users have a higher likelihood of developing type 2 diabetes, which is the most common form of the disease.
CNBC’s Jim Cramer is suggesting that investors buy into Funko, the $900 million toymaker that sells pop culture-related collectibles.
The Trump administration is considering a rule that would require hospitals to publicize the prices they negotiate with insurers.
The biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week’s surprise announcement from Food And Drug Administration Commissioner Scott Gottlieb that he will be stepping down next month.
Bristol-Myers Squibb CEO Giovanni Caforio defended his company’s $74 billion bid for cancer drug maker Celgene in an interview with CNBC’s Jim Cramer on Wednesday.
There’s no link between autism and the vaccine that prevents measles, mumps and rubella, according to a new study that challenges a push by some parents against vaccinating their children.
California Attorney General Xavier Becerra announced Monday that the state filed a lawsuit against the administration of President Donald Trump over its new rule that restricts access to abortions and other reproductive health services.
Reynolds American tobacco is tightening restrictions to buy its Vuse e-cigarettes online and running a national ad campaign to try to position itself as a leader in combating underage use amid a federal crackdown on teen vaping.
Livongo, a San Francisco start-up that sells tools to employers to help them manage the health of their workers with diabetes and other chronic conditions, hosted its first conference on Thursday.
CNBC’s Jim Cramer on Friday said Norwegian Cruise Line Holdings has caught his attention as a top performer with strong guidance in 2019.
Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $74 billion purchase of cancer drugmaker Celgene, the biggest acquisition announced so far this year.
The Food and Drug Administration will hold its first public hearings on CBD in April as the agency weighs rules allowing companies to add the popular cannabis-based compound to food, Commissioner Scott Gottlieb said Wednesday.
A senate panel on Tuesday grilled AbbVie Chairman and CEO Richard Gonzalez about the U.S. drugmaker’s arthritis treatment Humira, saying that tying executive bonuses to sales of the blockbuster drug was “problematic.”
Food and Drug Administration Commissioner Scott Gottlieb in an interview Tuesday blamed high drug prices, in part, on the “wacky” system where pharmaceutical companies discount their drugs but patients don’t see those savings.
Samsung announced a new line of wearables this week, including a new smartwatch called Galaxy Active. The device claimed to monitor users’ blood pressure, which some suggested would put it ahead of its key rival, Apple, as the first big tech player to make such an important breakthrough.
Switching to Juul e-cigarettes reduces smokers’ risk to cigarette toxins at similar levels to quitting entirely, according to results from a clinical trial presented at a conference Saturday.
Kraft Heinz is feeling the squeeze as the brand falls behind food consumption trends and faces other mounting struggles, Wolfe Research analyst Scott Mushkin told CNBC on Friday.
A diet with plenty of whole grains can decrease risk of liver cancer by nearly 40 percent, according to a new study published in JAMA Oncology on Thursday.
Social network Pinterest has taken a big step to stop the spread of false content that is damaging people’s health, which could put pressure on competitors to follow.
The Food and Drug Administration is discouraging people from being infused with young blood, a procedure that’s becoming increasingly common but hasn’t been proven to have medical benefits.